NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
12.06
-0.34 (-2.74%)
At close: Jan 30, 2026, 4:00 PM EST
12.19
+0.13 (1.08%)
After-hours: Jan 30, 2026, 7:31 PM EST
NeoGenomics Employees
NeoGenomics had 2,200 employees as of December 31, 2024. The number of employees increased by 100 or 4.76% compared to the previous year.
Employees
2,200
Change (1Y)
100
Growth (1Y)
4.76%
Revenue / Employee
$322,346
Profits / Employee
-$51,576
Market Cap
1.56B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 2,200 | 100 | 4.76% |
| Dec 31, 2023 | 2,100 | 0 | - |
| Dec 31, 2022 | 2,100 | 100 | 5.00% |
| Dec 31, 2021 | 2,000 | 300 | 17.65% |
| Dec 31, 2020 | 1,700 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| OPKO Health | 2,997 |
| Neogen | 2,974 |
| Fulgent Genetics | 1,313 |
| GeneDx Holdings | 1,000 |
| GRAIL | 1,000 |
| Twist Bioscience | 979 |
| Veracyte | 824 |
| Castle Biosciences | 823 |
NEO News
- 5 days ago - NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 - Business Wire
- 7 days ago - NeoGenomics: Distribution Moat In Community Oncology - Seeking Alpha
- 18 days ago - NeoGenomics, Inc. (NEO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 20 days ago - NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue - Business Wire
- 27 days ago - NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 4 weeks ago - NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors - Business Wire
- 6 weeks ago - NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation - Business Wire
- 7 weeks ago - NeoGenomics to Present New ctDNA Research at SABCS 2025 - Business Wire